DexCom
DXCM • NASDAQ • Stock Fundamentals
DexCom is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Jacob Steven Leach, with a market cap of $25.1B.
Market Cap$25.1B
Revenue TTM$4.8B
Net Income TTM$930.4M
P/E Ratio27.00
Net Margin19.31%
EPS TTM$2.33
Free Cash Flow TTM$1.4B
Employees9.6K
CEOJacob Steven Leach
CountryUnited States of America
Healthcare
Medical - Devices
Most Recent EarningsApr 30, 2026 · 20 days agoQ1 2026
View reportNext EarningsJul 29, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Gross Margin61.5%
Op. Margin21.45%
ROE35.62%
D/E4.84%
Current Ratio1.95
Total Debt$143.0M
Cash$1.1B
CapEx TTM$353.1M
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metric
DexCom FAQ
Common questions about DexCom
DexCom (DXCM) has a market capitalization of $25.1B and trades on NASDAQ.
DexCom generated $4.8B in trailing twelve-month revenue with net income of $930.4M, representing a net margin of 19.3%. Gross margin stands at 61.5%, with free cash flow of $1.4B. These figures are based on the Q1 2026 filing.
DexCom has approximately 9,600 employees.